MedTrace Logo

Meta-analysis of Stannous Fluoride Dentifrice and the Effects on Dentine Hypersensitivity

NCT04005417 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1036

Last updated 2019-07-02

No results posted yet for this study

Summary

The aim of this 11 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) on dentine hypersensitivity versus a positive or negative control dentifrice.

Conditions

  • Dentine Hypersensitivity

Interventions

DRUG

Stannous fluoride dentifrice

Stannous fluoride (0.454%) dentifrice

DRUG

Positive control dentifrice

Positive control dentifrice containing potassium nitrate or arginine.

DRUG

Negative control dentifrice

Negative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%)

Sponsors & Collaborators

  • Procter and Gamble

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-08
Primary Completion
2018-11-30
Completion
2018-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04005417 on ClinicalTrials.gov